AMLX Research and Charts

AMLX - Amylyx Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-13 (Delayed quote data 2025-05-09)

Last 4.61	Change ⇑ +0.03 (+0.66%)	Volume 982,524
	Open 4.62	High 4.82	Low 4.41

8EMA (Daily) 4.79	40EMA (Daily) 4.29	50EMA (Daily) 4.20	STO (Daily) 56.810	MACD Hist (Daily) -0.115
8EMA (Weekly) 4.405	40EMA (Weekly) 4.55	50EMA (Weekly) 5.12	STO (Weekly) 83.647	MACD Hist (Weekly) 0.456


Company Profile
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.